JP Morgan Chase’s Tevogen Inc TVGN Stock Holding History

JP Morgan Chase’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.47K	Sell	393 -86	-18%	-$687	﹤0.01%	7186
2026 Q1	$2.06K	Sell	479 -271	-36%	-$3.32K	﹤0.01%	7009
2025 Q4	$12.4K	Buy	750 +249	+50%	+$6.47K	﹤0.01%	6611
2025 Q3	$19.7K	Buy	501 +40	+9%	+$1.97K	﹤0.01%	6479
2025 Q2	$28.8K	Sell	461 -1,009	-69%	-$57.5K	﹤0.01%	6087
2025 Q1	$79.4K	Buy	1,470 +686	+88%	+$45.1K	﹤0.01%	5681
2024 Q4	$40.4K	Buy	784 +334	+74%	+$21.8K	﹤0.01%	6091
2024 Q3	$8.29K	Buy	450 +264	+142%	+$7.72K	﹤0.01%	6400
2024 Q2	$6.74K	Buy	186 +185	+18,500%	+$12.1K	﹤0.01%	6326
2024 Q1	$112	Buy	+1	New	+$362	﹤0.01%	6889
2022 Q3	–	Sell	-1,000	Closed	-$501K	–	6917
2022 Q2	$501K	Sell	1,000 -2,832	-74%	-$1.42M	﹤0.01%	4546
2022 Q1	$1.91M	Buy	+3,832	New	+$1.91M	﹤0.01%	3795

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

JP Morgan Chase's TVGN Position: Q2 2026 in Review

JP Morgan Chase reduced its Tevogen Inc (TVGN) stake by 18% in Q2 2026, selling an estimated $687 and leaving 393 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #7186.

JP Morgan Chase first reported a position in TVGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.91M in Q1 2022. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

JP Morgan Chase held 393 shares of Tevogen Inc worth $2.47K as of Q2 2026.
JP Morgan Chase sold 86 Tevogen Inc shares in Q2 2026, an estimated $687.
Tevogen Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7186 holding.
JP Morgan Chase first reported a position in Tevogen Inc in Q1 2022 and has held it in 12 quarters since.
JP Morgan Chase's Tevogen Inc position peaked at $1.91M in Q1 2022.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.